MS News That Caught My Eye Last Week: DMTs and Age, Lyvispah, Cells Driving MS, Melatonin

MS News That Caught My Eye Last Week: DMTs and Age, Lyvispah, Cells Driving MS, Melatonin

314103

MS News That Caught My Eye Last Week: DMTs and Age, Lyvispah, Cells Driving MS, Melatonin

Worsening of Disability Evident in Older Patients Who Stop DMTs Some neurologists believe that multiple sclerosis (MS) progression slows, or even stops, when people reach their 60s, so they advise patients that there’s no need to continue their disease-modifying therapies (DMTs). Personally, I think a DMT age ceiling is ill-advised. This study agrees. While older multiple sclerosis (MS) patients whose conditions are stable commonly stop using disease-modifying therapies (DMTs), a study indicates that for a…

You must be logged in to read/download the full post.